Philip Kam Tao Li, Agnes Shin Man Choy, Sunita Bavanandan, Wei Chen, Marjorie Foo, Talerngsak Kanjanabuch, Yong-Lim Kim, Masaaki Nakayama, Xueqing Yu
Anemia is an important complication in patients with chronic kidney disease. Peritoneal dialysis (PD) is one of the most common modalities of kidney replacement therapy for patients with end-stage kidney disease. PD is particularly prevalent in the Asian Pacific region. Among the different countries and regions, including mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, and Thailand, PD accounts for 2.8% to 74.6% of the dialysis population. In addition, 82% to 96% of the PD populations from these countries and regions are receiving erythropoiesis-stimulating agents (ESAs)...
May 2021: Kidney medicine